| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1806321-10-7 | 3,5-Difluoro-4-methylbenzoic acid methyl ester | Csub9/subHsub8/subFsub2/subOsub2/sub |
| 1806386-01-5 | 3-Fluoro-6-(trifluoromethyl)-2-pyridinecarboxylic acid ethyl ester | Csub9/subHsub7/subFsub4/subNOsub2/sub |
| 1806469-15-7 | Pantoprazole Impurity 5 | Csub8/subHsub6/subFsub2/subNsub2/subOsub2/sub |
| 1807009-09-1 | 6-Bromo-2,3-dichlorobenzyl alcohol | Csub7/subHsub5/subBrClsub2/subO |
| 1807020-38-7 | 2-Fluoro-4-(trifluoromethyl)-3-pyridinamine | Csub6/subHsub4/subFsub4/subNsub2/sub |
| 1807056-85-4 | 1,2-Dibromo-4-fluoro-5-nitrobenzene | Csub6/subHsub2/subBrsub2/subFNOsub2/sub |
| 1807100-39-5 | 3-Amino-6-(trifluoromethyl)pyridine-2-carboxylic acid ethyl ester | Csub9/subHsub9/subFsub3/subNsub2/subOsub2/sub |
| 1807117-78-7 | 5-Bromo-3-fluoro-2-methylbenzonitrile | Csub8/subHsub5/subBrFN |
| 1807135-08-5 | 2-Bromo-1,5-difluoro-3-methylbenzene | Csub7/subHsub5/subBrFsub2/sub |
| 1807191-86-1 | 6-Bromo-3-fluoro-2-methylbenzoic acid methyl ester | Csub9/subHsub8/subBrFOsub2/sub |
| 1807197-86-9 | 2-Bromo-3,4-difluoropyridine | Csub5/subHsub2/subBrFsub2/subN |
| 1807206-49-0 | 2-Bromo-4-(trifluoromethyl)-3-pyridinecarbonitrile | Csub7/subHsub2/subBrFsub3/subNsub2/sub |
| 1807221-07-3 | Ethyl 4-bromo-6-chloronicotinate | Csub8/subHsub7/subBrClNOsub2/sub |
| 1807224-98-1 | 1-Bromo-5-methoxy-4-methyl-2-nitrobenzene | Csub8/subHsub8/subBrNOsub3/sub |
| 1807232-33-2 | 2-Bromo-6-fluoro-4-methylbenzoic acid methyl ester | Csub9/subHsub8/subBrFOsub2/sub |
| 1807315-98-5 | N1-[(1S,2R,4S)-2-amino-4-(dimethylcarbamoyl)cyclohexyl]-N2-(5-chloropyridin-2-yl)ethanediamide methanesulfonic acid | Csub17/subHsub26/subClNsub5/subOsub6/subS |
| 1807350-91-9 | (S)-Ethyl pyrrolidine-3-carboxylate hydrochloride | Csub7/subHsub13/subNOsub2/sub.HCl |
| 1807455-76-0 | 5-Chloro-N-[4-[(5S)-5-[[[(5-chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]-N-[2-[2-(methylamino)-2-oxoethoxy]ethyl]-2-thiophenecarboxamide | Csub25/subHsub24/subClsub2/subNsub4/subOsub6/subSsub2/sub |
| 1807501-86-5 | endo-BCN-PEG4-NHS ester | Csub26/subHsub38/subNsub2/subOsub10/sub |
| 1807503-92-9 | 3-[2-(2-Bromoethoxy)ethoxy]propanoic acid | Csub7/subHsub13/subBrOsub4/sub |
| 1807505-02-7 | N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)propionamide | Csub28/subHsub31/subNsub7/subOsub2/sub |
| 1807523-99-4 | 4-(Methylsulfonyl)-1-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1H-1,2,4-triazol-1-yl]methyl]phenyl]piperidine hydrochloride (1:1) | Csub25/subHsub25/subFsub3/subNsub6/subOsub4/subS.HCl |
| 1807529-70-9 | Cy5-Amine chloride hydrochloride | Csub38/subHsub54/subClsub2/subNsub4/subO |
| 1807536-06-6 | 2-(4-Fluorophenyl)ethylamine Hydrobromide | Csub8/subHsub11/subBrFN |
| 1807536-66-8 | N1,N1'-[1,6-Hexanediylbis(oxy-4,1-phenylene)]bis[N1-methyl-1,4-benzenediamine] | Csub32/subHsub38/subNsub4/subOsub2/sub |
| 1807537-27-4 | O-[2-[2-[2-(2-Propyn-1-yloxy)ethoxy]ethoxy]ethyl]hydroxylamine | Csub9/subHsub17/subNOsub4/sub |
| 1807537-38-7 | 3-[2-[2-[2-[2-(Aminooxy)ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid | Csub11/subHsub23/subNOsub7/sub |
| 1807607-93-7 | Bepotastine Isopropyl Ester | Csub24/subHsub31/subClNsub2/subOsub3/sub |
| 1807607-99-3 | (3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,1-Dioxido-1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione | Csub28/subHsub36/subNsub4/subOsub4/subS |
| 1807632-93-4 | Dapagliflozin Impurity 17 | Csub15/subHsub14/subBrsub2/subO |
| 1807632-95-6 | Dapagliflozin Impurity 3 | Csub21/subHsub25/subBrOsub6/sub |
| 1807642-39-2 | 5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-carbonitrile | Csub16/subHsub10/subFNsub3/subOsub2/subS |
| 1807712-44-2 | 9-phenyl-N-(3-phenylphenyl)carbazol-2-amine | Csub30/subHsub22/subNsub2/sub |
| 1807732-38-2 | Celosin I (Bai-Ping Ma) | Csub53/subHsub82/subOsub24/sub |
| 1807758-81-1 | SIRT7 inhibitor 97491 | Csub15/subHsub12/subClNsub3/subO |
| 1807861-48-8 | 2,4,6,7,8,9-Hexahydro-7-(phenylmethyl)-4-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one | Csub24/subHsub23/subFsub3/subNsub4/subO |
| 1807920-97-3 | (2R)-2-amino-2-[3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl]acetic acid hydrochloride | Csub8/subHsub11/subClFsub3/subNOsub2/sub |
| 1807941-46-3 | 3-Methoxycyclobutanol | Csub5/subHsub10/subOsub2/sub |
| 1807983-61-4 | Lurasidone Impurity 22 | Csub32/subHsub38/subNsub6/subOsub4/subSsub2/sub |
| 1807983-62-5 | Lurasidone Impurity 6 | Csub29/subHsub36/subNsub4/subOsub4/subS |
| 1807983-63-6 | Lurasidone Impurity 7 | Csub31/subHsub38/subNsub6/subOsub2/subSsub2/sub |
| 1807988-02-8 | Bictegravir sodium | Csub21/subHsub18/subFsub3/subNsub3/subOsub5/sub.Na |
| 1808087-53-7 | Gliclazide Impurity E | Csub15/subHsub19/subNsub3/subOsub3/subS |
| 1808159-02-5 | Qingyangshengenin 3-O-α-L-cymaropyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside | Csub56/subHsub84/subOsub20/sub |
| 1808248-05-6 | Linvencorvir | Csub29/subHsub35/subFNsub6/subOsub5/subS |
| 1808248-61-4 | (S)-Hexahydroimidazo[1,5-a]pyrazin-3(2H)-one | Csub6/subHsub11/subNsub3/subO |
| 1808258-21-0 / 113440-58-7 | Calicheamicins | |
| 1808997-73-0 | Tert-butyl 2-(cyanomethyl)piperazine-1-carboxylate | Csub11/subHsub19/subNsub3/subOsub2/sub |
| 1809010-50-1 | Berotralstat | Csub30/subHsub26/subFsub4/subNsub6/subO |
| 1809031-16-0 | (2S,6R)-N,2-Bis(4-fluorophenyl)tetrahydro-6-(4-hydroxyphenyl)-2H-pyran-4-carboxamide | Csub24/subHsub21/subFsub2/subNOsub3/sub |